-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NeuroBo Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- NeuroBo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.65M, a 48% decline year-over-year.
- NeuroBo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$27.7M, a 134% decline year-over-year.
- NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 10.7% increase from 2022.
- NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14M, a 8.62% increase from 2021.
- NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15.3M, a 48.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)